Whitening and moisturizing skin care product

A skin care product and whitening technology, applied in skin care preparations, cosmetics, cosmetic preparations, etc., can solve problems such as difficult to treat both symptoms and root causes, poor water solubility, high price, etc., to enhance water-locking ability, inhibit expression, and reduce melanin The effect of content

Active Publication Date: 2020-06-05
深圳市百吉因生物科技有限公司
View PDF9 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, most of these products are chemical preparations with poor water solubility, so they need to be used in large quantities or for a long time to effectively achieve the whitening and anti-aging effect. side effects, the price is also expensive, and it is difficult to achieve the goal of treating both symptoms and root causes

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Whitening and moisturizing skin care product
  • Whitening and moisturizing skin care product
  • Whitening and moisturizing skin care product

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Add the raw materials for the preparation of the solvent into the water phase pot of the homogeneous emulsifier according to the following formula and stir at 400 rpm: 0.925 grams of water, 0.05 grams of glycerin, 0.003 grams of tranexamic acid, 0.002 grams of glutathione, and 0.001 grams of butanediol , 0.001 gram of taurine, 0.001 gram of potassium methoxysalicylate, 0.001 gram of caprylic acid ester, 0.002 gram of caprylyl hydroxamic acid, 0.001 gram of p-hydroxyacetophenone, 0.001 gram of carnosine, 0.002 gram of Alcaligenes multi Sugar, 0.003 g of dipotassium glycyrrhizinate, 0.005 g of sodium hyaluronate, and 0.002 g of phenoxyethanol were stirred for 20 minutes and then added with transdermal decapeptide-4 and P-siRNA1. The ratio of the three was 1 g of solvent: 0.1 mg of transdermal Skin decapeptide-4: 10ng P-siRNA1, and continue stirring for 10 minutes to obtain the whitening and moisturizing skin care product of Example 1.

Embodiment 2

[0044] It is basically the same as Example 1, except that the ratio of the three is 1g solvent: 0.1mg transdermal decapeptide-4: 25ng P-siRNA1, and the whitening and moisturizing skin care product of Example 2 is obtained.

Embodiment 3

[0046] It is basically the same as Example 1, except that the ratio of the three is 1g solvent: 0.1mg transdermal decapeptide-4: 50ng P-siRNA1, and the whitening and moisturizing skin care product of Example 3 is obtained.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention discloses a whitening and moisturizing skin care product. The whitening and moisturizing skin care product comprises a solvent, a transdermal peptide and a small interfering nucleic acid for P gene, wherein the solvent is prepared from the following raw materials: water, glycerin, tranexamic acid, glutathione, butanediol, taurine, potassium methoxysalicylate, glyceryl caprylate, octanoyl hydroxamic acid, p-hydroxyacetophenone, carnosine, alcaligenes polysaccharides, dipotassium glycyrrhizinate, sodium hyaluronate and phenoxyethanol; and a ratio of the solvent, transdermalpeptide and small interfering nucleic acid for P gene is 1 g of solvent:(0.1-0.5) mg of transdermal peptide:(10-50) ng of small interfering nucleic acid for P gene. The whitening and moisturizing skin care product can also include 2-5% of arbutin.

Description

technical field [0001] The invention relates to the technical field of cosmetics, in particular to a whitening and moisturizing skin care product. Background technique [0002] In 1998, Andrew Z.Fire and Craig C.Mello jointly discovered the mechanism of RNA interference in vivo, and they jointly won the Nobel Prize in Physiology and Medicine in 2006. This has opened a door for the development of a new generation of drugs (RNA interference drugs) against viruses, cancer and other serious diseases. The RNA interference drug has the advantages of novel mode of action, clear mechanism of action, strong targeting and less side effects. RNA interference (RNA interference, RNAi) is a phenomenon in which double-stranded RNA (double-stranded RNA, dsRNA) molecules shut down or silence the expression of homologous genes at the mRNA level. RNA interference technology, also known as gene knockdown (knock-down) or gene silencing (gene silencing), is a typical post-transcriptional gene r...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K8/73A61K8/64A61K8/60A61Q19/00A61Q19/02
CPCA61K8/735A61K8/606A61K8/64A61K8/602A61Q19/00A61Q19/02
Inventor 汤涛邓艳宋艺东硕
Owner 深圳市百吉因生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap